Deenan Pillay is a clinical academic in the translational arena of HIV drug resistance and transmission. He is Deputy Director of Clinical Research at i-sense and Director of the Wellcome Trust Africa Centre for Health and Population studies, based at the University of KwaZulu-Natal, and a key partner in i-sense's Flagship 4 programme.
After gaining a PhD in Metabolic Biochemistry and qualifying in Medicine at the University of Newcastle-upon-Tyne, Deenan undertook specialist training in clinical virology, with a Fellowship at UCSD in 1993 in the lab of Doug Richman to research HIV drug resistance. He subsequently led the UK National Reference Laboratory in Antiviral Susceptibility in Birmingham, before moving to UCL where he became Head of Division of Infection and Immunity and Professor of Virology. At the same time, he has remained clinically active as a Consultant Medical Virologist, working in University College London Hospital, as well as continuing to lead the antiviral programme for the UK Health Protection Agency. Deenan was appointed by the Wellcome Trust as Director of the Africa Centre in September 2013, through a secondment from UCL.